TSRI zooming over $13. This one has held up like a champ in this tough market. I sold too soon, hopefully some are still holding. Great report earlier this month. With fiscal Q2 earnings of .12/share and $3/share in cash on the balance sheet, I thought fair value was around $10. But I guess traders like the strong revenue growth and low float.